← Leaderboards
Melissa Ann Fath
University Of Iowa
$775,635
Attributed
$775,635
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $155.1K · FY2019–23$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$775,635 · 1
By mechanism
R50$775,635 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- George J Weiner$29,916,936
- Joseph J Cullen$5,964,157
- Garry R Buettner$6,434,018
- Daniel M. Quinn$3,448,198
- Bryan Allen$2,697,856
Others in their field
Other Emerging Leaders on “Intravenous”
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
- Xinhua Li · Nano Terra, Inc.$18,709,887
- James Dale Berry · Brigham And Women'S Hospital$17,050,216
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
Research focus
IntravenousIn VitroHydrogen PeroxideAscorbateGrantCancer BiologyCancer CellAwardChemoradiationBiological MarkersBiologyAscorbic AcidClinical ResearchClinical TrialsCore FacilityDna DamageDoseCancer TherapyEnvironmentFree RadicalsFundingGenetic ApproachGlioblastomaIn Vivo
Grant awards (5)
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy$155,127
R50 · FY2023 · CA · contact PI
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy$155,127
R50 · FY2022 · CA · contact PI
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy$155,127
R50 · FY2021 · CA · contact PI
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy$155,127
R50 · FY2020 · CA · contact PI
Repurposing redox active agents for exploiting differences in cancer cell metabolism for improving cancer therapy$155,127
R50 · FY2019 · CA · contact PI